| Dr Amy K Reisenauer, MD | |
|
1300 N Holopono St Ste 215, Kihei, HI 96753-6945 | |
| (808) 874-3444 | |
| (808) 874-3443 |
| Full Name | Dr Amy K Reisenauer |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 27 Years |
| Location | 1300 N Holopono St Ste 215, Kihei, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104927110 | NPI | - | NPPES |
| 0000255125 | Other | HI | HMSA BILLING NUMBER |
| 572710-01 | Medicaid | HI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ND0900X | Dermatology - Dermatopathology | MD-13436 (Hawaii) | Primary |
| Entity Name | Hawaii Dermatopathology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780120709 PECOS PAC ID: 5294004396 Enrollment ID: O20170705002702 |
News Archive
Many people who have completed Standard Process's Purification Program asked for ways to continue their journey toward better health and weight management after the 21-day purification program. In response, Standard Process developed and now offers its new Post-Purification Program and Product Kits.
The privacy rule of the Health Insurance Portability and Accountability Act (HIPAA) is having a negative impact on the advance of biomedical research and the search for treatments that benefit society, says a newly-released report by the Association of Academic Health Centers (AAHC).
Pharmaxis has announced it had received notification from the United States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol bronchial challenge test Aridol has been accepted for standard review. The FDA will advise the result of the review on 27 December 2009.
Researchers at the University of Washington have used a noninvasive light-based imaging technology to literally see inside the living brain, providing a new tool to study how diseases like dementia, Alzheimer's, and brain tumors change brain tissue over time.
› Verified 7 days ago
| Entity Name | Amy Reisenauer Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922550987 PECOS PAC ID: 3173892809 Enrollment ID: O20170711003419 |
News Archive
Many people who have completed Standard Process's Purification Program asked for ways to continue their journey toward better health and weight management after the 21-day purification program. In response, Standard Process developed and now offers its new Post-Purification Program and Product Kits.
The privacy rule of the Health Insurance Portability and Accountability Act (HIPAA) is having a negative impact on the advance of biomedical research and the search for treatments that benefit society, says a newly-released report by the Association of Academic Health Centers (AAHC).
Pharmaxis has announced it had received notification from the United States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol bronchial challenge test Aridol has been accepted for standard review. The FDA will advise the result of the review on 27 December 2009.
Researchers at the University of Washington have used a noninvasive light-based imaging technology to literally see inside the living brain, providing a new tool to study how diseases like dementia, Alzheimer's, and brain tumors change brain tissue over time.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy K Reisenauer, MD 1300 N Holopono St Ste 215, Kihei, HI 96753-6945 Ph: (808) 874-3444 | Dr Amy K Reisenauer, MD 1300 N Holopono St Ste 215, Kihei, HI 96753-6945 Ph: (808) 874-3444 |
News Archive
Many people who have completed Standard Process's Purification Program asked for ways to continue their journey toward better health and weight management after the 21-day purification program. In response, Standard Process developed and now offers its new Post-Purification Program and Product Kits.
The privacy rule of the Health Insurance Portability and Accountability Act (HIPAA) is having a negative impact on the advance of biomedical research and the search for treatments that benefit society, says a newly-released report by the Association of Academic Health Centers (AAHC).
Pharmaxis has announced it had received notification from the United States Food and Drug Administration (FDA) that the New Drug Application (NDA) for its mannitol bronchial challenge test Aridol has been accepted for standard review. The FDA will advise the result of the review on 27 December 2009.
Researchers at the University of Washington have used a noninvasive light-based imaging technology to literally see inside the living brain, providing a new tool to study how diseases like dementia, Alzheimer's, and brain tumors change brain tissue over time.
› Verified 7 days ago
Dr. George M Martin, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 161 Wailea Ike Pl Ste A104, Kihei, HI 96753 Phone: 808-875-0511 Fax: 808-875-8595 | |
Heather Irene Bejenaru, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 161 Wailea Ike Pl Ste A104, Kihei, HI 96753 Phone: 808-875-0511 Fax: 808-875-8595 | |
John Marshall Knox Ii, MD Dermatology Medicare: Medicare Enrolled Practice Location: 375 Huku Lii Pl, Suite 201, Kihei, HI 96753 Phone: 808-875-7477 Fax: 808-879-4585 | |
Dr. Kenny R Malott, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 375 Huku Lii Pl, Suite 201, Kihei, HI 96753 Phone: 808-875-7546 Fax: 808-879-4585 |